Click here to go to the previous page
China: Pharmaceutical Development in an Emerging Market
Program Code:
REG010
Date:
Tuesday, May 8, 2007
Time:
11:00 AM to 12:30 PM
CHAIR
:
Lawrence Sung, PhD, Partner, Nixon Peabody LLP
SPEAKER
(S):
Soonhee Jang, Patent Counsel, Regional Counsel-Asian IP Enforcement, Eli Lilly & Company
Wendy Wang, Markham International Education Center
Description
China has vast resources and growing interest in participating as a key player in the worldwide drug development market. This session will examine the underlying issues the pharmaceutical industry needs to address when investing in China and developing clinical trial capabilities in that country.
Objectives:
Offer information about the regulatory structure in China.
Describe the state of human subject protection regulations and enforcement in China.
Foster an understanding of the commercial aspects of running clinical trials in China, including patent protection, foreign ownership issues and enforcement.